Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis

World Journal of Gastroenterology

Volumn 21, Issue 21, 2015, Pages 6649-6659

  Lu, Le Le ^a   Sun, Jing ^a   Lai, Jie Juan ^a   Jiang, Yan ^a   Bai, Lian Hua ^a   Zhang, Lei Da ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Neuron glial antigen 2; Poor prognosis; Prognostic marker; Survival analysis

Indexed keywords

ANTIGEN; NEURON GLIAL ANTIGEN 2; TUMOR MARKER; UNCLASSIFIED DRUG; CHONDROITIN SULFATE PROTEOGLYCAN 4; CSPG4 PROTEIN, HUMAN; MEMBRANE PROTEIN; PROTEOCHONDROITIN SULFATE; PROTEOGLYCAN;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PORTAL VEIN; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TUMOR INVASION; WESTERN BLOTTING; CANCER STAGING; CHEMISTRY; CHI SQUARE DISTRIBUTION; GENETICS; LIVER TUMOR; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; RETROSPECTIVE STUDY; RISK FACTOR; TIME FACTOR; UPREGULATION;

ANTIGENS; BIOMARKERS, TUMOR; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CHI-SQUARE DISTRIBUTION; CHONDROITIN SULFATE PROTEOGLYCANS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; PROTEOGLYCANS; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; UP-REGULATION;

EID: 84930805654     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i21.6649     Document Type: Article

References (32)

1. Yang ZQ, Yang ZY, Zhang LD, Ping-Bie SG, Ma KS, Li XW, Dong JH. Increased liver-infiltrating CD8+FoxP3+ regulatory T cells are associated with tumor stage in hepatocellular carcinoma patients. Hum Immunol 2010; 71: 1180-1186 [PMID: 20870003 DOI: 10.1016/j.humimm.2010.09.011]
2. Kondo K, Chijiiwa K, Makino I, Kai M, Maehara N, Ohuchida J, Naganuma S. Risk factors for early death after liver resection in patients with solitary hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 2005; 12: 399-404 [PMID: 16258809 DOI: 10.1007/s00534-005-1009-9]
3. Khan AS, Fowler KJ, Chapman WC. Current surgical treatment strategies for hepatocellular carcinoma in North America. World J Gastroenterol 2014; 20: 15007-15017 [PMID: 25386049 DOI: 10.3748/wjg.v20.i41.15007]
4. Trotter J, Karram K, Nishiyama A. NG2 cells: Properties, progeny and origin. Brain Res Rev 2010; 63: 72-82 [PMID: 20043946 DOI: 10.1016/j.brainresrev.2009.12.006]
5. Sakry D, Karram K, Trotter J. Synapses between NG2 glia and neurons. J Anat 2011; 219: 2-7 [PMID: 21395579 DOI: 10.1111/j.1469-7580.2011.01359.x]
6. O'Brien CA, Kreso A, Jamieson CH. Cancer stem cells and self-renewal. Clin Cancer Res 2010; 16: 3113-3120 [PMID: 20530701 DOI: 10.1158/1078-0432.CCR-09-2824]
7. Russell KC, Tucker HA, Bunnell BA, Andreeff M, Schober W, Gaynor AS, Strickler KL, Lin S, Lacey MR, O'Connor KC. Cell-surface expression of neuron-glial antigen 2 (NG2) and melanoma cell adhesion molecule (CD146) in heterogeneous cultures of marrow-derived mesenchymal stem cells. Tissue Eng Part A 2013; 19: 2253-2266 [PMID: 23611563 DOI: 10.1089/ten. TEA.2012.0649]
8. Benassi MS, Pazzaglia L, Chiechi A, Alberghini M, Conti A, Cattaruzza S, Wassermann B, Picci P, Perris R. NG2 expression predicts the metastasis formation in soft-tissue sarcoma patients. J Orthop Res 2009; 27: 135-140 [PMID: 18634019 DOI: 10.1002/jor.20694]
9. Stallcup WB, Huang FJ. A role for the NG2 proteoglycan in glioma progression. Cell Adh Migr 2008; 2: 192-201 [PMID: 19262111]
10. Seyfried NT, Huysentruyt LC, Atwood JA, Xia Q, Seyfried TN, Orlando R. Up-regulation of NG2 proteoglycan and interferon-induced transmembrane proteins 1 and 3 in mouse astrocytoma: a membrane proteomics approach. Cancer Lett 2008; 263: 243-252 [PMID: 18281150 DOI: 10.1016/j.canlet.2008.01.007]
11. Mauvieux L, Delabesse E, Bourquelot P, Radford-Weiss I, Bennaceur A, Flandrin G, Valensi F, MacIntyre EA. NG2 expression in MLL rearranged acute myeloid leukaemia is restricted to monoblastic cases. Br J Haematol 1999; 107: 674-676 [PMID: 10583275]
12. Petrini S, Tessa A, Stallcup WB, Sabatelli P, Pescatori M, Giusti B, Carrozzo R, Verardo M, Bergamin N, Columbaro M, Bernardini C, Merlini L, Pepe G, Bonaldo P, Bertini E. Altered expression of the MCSP/NG2 chondroitin sulfate proteoglycan in collagen VI deficiency. Mol Cell Neurosci 2005; 30: 408-417 [PMID: 16169245 DOI: 10.1016/j.mcn.2005.08.005]
13. Xiong J, Wang Y, Zhu Z, Liu J, Wang Y, Zhang C, Hammes HP, Lang F, Feng Y. NG2 proteoglycan increases mesangial cell proliferation and extracellular matrix production. Biochem Biophys Res Commun 2007; 361: 960-967 [PMID: 17686464 DOI: 10.1016/j.bbrc.2007.07.113]
14. Cattaruzza S, Nicolosi PA, Braghetta P, Pazzaglia L, Benassi MS, Picci P, Lacrima K, Zanocco D, Rizzo E, Stallcup WB, Colombatti A, Perris R. NG2/CSPG4-collagen type VI interplays putatively involved in the microenvironmental control of tumour engraftment and local expansion. J Mol Cell Biol 2013; 5: 176-193 [PMID: 23559515 DOI: 10.1093/jmcb/mjt010]
15. Birbrair A, Zhang T, Wang ZM, Messi ML, Enikolopov GN, Mintz A, Delbono O. Skeletal muscle neural progenitor cells exhibit properties of NG2-glia. Exp Cell Res 2013; 319: 45-63 [PMID: 22999866 DOI: 10.1016/j.yexcr.2012.09.008]
16. Dede K, Salamon F, Landherr L, Jakab F, Bursics A. Pathologic assessment of response to chemotherapy in colorectal cancer liver metastases after hepatic resection: which method to use? Pathol Oncol Res 2015; 21: 173-179 [PMID: 24898285 DOI: 10.1007/s12253-014-9803-9]
17. Schnabel CL, Wagner S, Wagner B, Durán MC, Babasyan S, Nolte I, Pfarrer C, Feige K, Murua Escobar H, Cavalleri JM. Evaluation of the reactivity of commercially available monoclonal antibodies with equine cytokines. Vet Immunol Immunopathol 2013; 156: 1-19 [PMID: 24139393 DOI: 10.1016/j.vetimm.2013.09.012]
18. Bueno C, Montes R, Martín L, Prat I, Hernandez MC, Orfao A, Menendez P. NG2 antigen is expressed in CD34+ HPCs and plasmacytoid dendritic cell precursors: is NG2 expression in leukemia dependent on the target cell where leukemogenesis is triggered? Leukemia 2008; 22: 1475-1478 [PMID: 18698324 DOI: 10.1038/leu.2008.134]
19. Price MA, Colvin Wanshura LE, Yang J, Carlson J, Xiang B, Li G, Ferrone S, Dudek AZ, Turley EA, McCarthy JB. CSPG4, a potential therapeutic target, facilitates malignant progression of melanoma. Pigment Cell Melanoma Res 2011; 24: 1148-1157 [PMID: 22004131 DOI: 10.1111/j.1755-148X.2011.00929.x]
20. Ishii A, Fyffe-Maricich SL, Furusho M, Miller RH, Bansal R. ERK1/ERK2 MAPK signaling is required to increase myelin thickness independent of oligodendrocyte differentiation and initiation of myelination. J Neurosci 2012; 32: 8855-8864 [PMID:22745486 DOI: 10.1523/jneurosci.0137-12.2012]
21. You WK, Yotsumoto F, Sakimura K, Adams RH, Stallcup WB. NG2 proteoglycan promotes tumor vascularization via integrin-dependent effects on pericyte function. Angiogenesis 2014; 17: 61-76 [PMID: 23925489 DOI: 10.1007/s10456-013-9378-1]
22. Chekenya M, Krakstad C, Svendsen A, Netland IA, Staalesen V, Tysnes BB, Selheim F, Wang J, Sakariassen PØ, Sandal T, Lønning PE, Flatmark T, Enger PØ, Bjerkvig R, Sioud M, Stallcup WB. The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling. Oncogene 2008; 27: 5182-5194 [PMID: 18469852 DOI: 10.1038/onc.2008.157]
23. Liu H, Shubayev VI. Matrix metalloproteinase-9 controls proliferation of NG2+ progenitor cells immediately after spinal cord injury. Exp Neurol 2011; 231: 236-246 [PMID: 21756907 DOI: 10.1016/j.expneurol.2011.06.015]
24. Joo NE, Miao D, Bermúdez M, Stallcup WB, Kapila YL. Shedding of NG2 by MMP-13 attenuates anoikis. DNA Cell Biol 2014; 33: 854-862 [PMID: 25166220 DOI: 10.1089/dna.2014.2399]
25. Schultz N, Nielsen HM, Minthon L, Wennström M. Involvement of matrix metalloproteinase-9 in amyloid-β 1-42-induced shedding of the pericyte proteoglycan NG2. J Neuropathol Exp Neurol 2014; 73: 684-692 [PMID: 24918635 DOI: 10.1097/NEN.0000000000000084]
26. Wang J, Svendsen A, Kmiecik J, Immervoll H, Skaftnesmo KO, Planagumà J, Reed RK, Bjerkvig R, Miletic H, Enger PØ, Rygh CB, Chekenya M. Targeting the NG2/CSPG4 proteoglycan retards tumour growth and angiogenesis in preclinical models of GBM and melanoma. PLoS One 2011; 6: e23062 [PMID: 21829586 DOI: 10.1371/journal.pone.0023062]
27. Van Sinderen M, Cuman C, Winship A, Menkhorst E, Dimitriadis E. The chrondroitin sulfate proteoglycan (CSPG4) regulates human trophoblast function. Placenta 2013; 34: 907-912 [PMID: 23953863 DOI: 10.1016/j.placenta.2013.07.065]
28. Girolamo F, Dallatomasina A, Rizzi M, Errede M, Wälchli T, Mucignat MT, Frei K, Roncali L, Perris R, Virgintino D. Diversified expression of NG2/CSPG4 isoforms in glioblastoma and human foetal brain identifies pericyte subsets. PLoS One 2013; 8: e84883 [PMID: 24386429 DOI: 10.1371/journal.pone.0084883]
29. Doane KJ, Howell SJ, Birk DE. Identification and functional characterization of two type VI collagen receptors, alpha 3 beta 1 integrin and NG2, during avian corneal stromal development. Invest Ophthalmol Vis Sci 1998; 39: 263-275 [PMID: 9477982]
30. Iida J, Meijne AM, Spiro RC, Roos E, Furcht LT, McCarthy JB. Spreading and focal contact formation of human melanoma cells in response to the stimulation of both melanoma-associated proteoglycan (NG2) and alpha 4 beta 1 integrin. Cancer Res 1995; 55: 2177-2185 [PMID: 7743521]
31. Aya-ay J, Mayer J, Eakin AK, Muffly BG, Anello M, Sandy JD, Gottschall PE. The effect of hypoxic-ischemic brain injury in perinatal rats on the abundance and proteolysis of brevican and NG2. Exp Neurol 2005; 193: 149-162 [PMID: 15817274 DOI: 10.1016/j.expneurol.2004.11.021]
32. Morita S, Hourai A, Miyata S. Changes in pericytic expression of NG2 and PDGFRB and vascular permeability in the sensory circumventricular organs of adult mouse by osmotic stimulation. Cell Biochem Funct 2014; 32: 51-61 [PMID: 23629811 DOI: 10.1002/cbf.2971]